NDC 61958-1101 – Complera
Emtricitabine 200 mg/1; Rilpivirine Hydrochloride 25 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral
Product NDC61958-1101
Product details
- Brand name
- Complera
- Generic name
- Emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA202123
- Marketed since
- August 10, 2011
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Emtricitabine 200 mg/1
- Rilpivirine Hydrochloride 25 mg/1
- Tenofovir Disoproxil Fumarate 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61958-1101-1 | 30 TABLET, FILM COATED in 1 BOTTLE (61958-1101-1) | Aug 10, 2011 |